News

The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s ...
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for ...
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.
A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...
The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The state's new law marks one of the largest government investments into psychedelics to date, with advocates citing the drug ...
A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster ...